Skip to main content
Equibles

MetLife Investment Management, LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1529735 Whippany, NJ
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$968,264
-$12,890,524 QoQ
Shares Held
52,709
-92.6% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#106
of 215 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. VRDN ranks #84 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in VRDN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $968,264 52,709
2026-03-31 $13,858,788 708,527
2025-12-31 $1,368,813 43,985
2025-09-30 $941,513 43,629
2025-06-30 $609,933 43,629
2025-03-31 $588,118 43,629
2024-12-31 $849,135 44,295
2024-09-30 $827,667 36,381
2024-06-30 $473,316 36,381
2024-03-31 $447,730 25,570
2023-12-31 $485,062 22,271
2023-09-30 $341,637 22,271
2023-06-30 $529,827 22,271
2023-03-31 $504,805 19,843
2022-12-31 $579,614 19,843
2022-09-30 $281,274 13,714
2022-06-30 $158,670 13,714